Extracellular virulence factors of streptococci associated with animal diseases

Frontiers in Bioscience

Volumn 9, Issue , 2004, Pages 1157-1188

  Segura, Mariela ^a   Gottschalk, Marcelo ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Animal Disease; Bacteria; Capsule; M proteins; Microorganism; Review; Streptococci; Toxins; Virulence Factors

Indexed keywords

BACTERIAL ENZYME; BACTERIAL PROTEIN; BACTERIOCIN; CYCLIC AMP; EXOTOXIN; FIBRONECTIN BINDING PROTEIN; FIMBRIA PROTEIN; HEMOLYSIN; HYALURONIDASE; M LIKE PROTEIN; MEMBRANE PROTEIN; PROTEINASE; STREPTOKINASE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ANIMAL DISEASE; BACTERIAL GROWTH; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CELL DEATH; HOST CELL; IMMUNE SYSTEM; NONHUMAN; PATHOGENICITY; PROTEIN FUNCTION; REVIEW; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS BOVIS; STREPTOCOCCUS CANIS; STREPTOCOCCUS DYSGALACTIAE; STREPTOCOCCUS EQUI; STREPTOCOCCUS GALLOLYTICUS; STREPTOCOCCUS INIAE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PORCINUS; STREPTOCOCCUS SUIS; STREPTOCOCCUS UBERIS; ANIMAL; CATTLE; CATTLE DISEASE; EXTRACELLULAR SPACE; HORSE; HORSE DISEASE; MICROBIOLOGY; PHYSIOLOGY; STREPTOCOCCUS; STREPTOCOCCUS INFECTION; SWINE; SWINE DISEASE;

ANIMALIA; BACTERIA (MICROORGANISMS); CANIS; STREPTOCOCCUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS BOVIS; STREPTOCOCCUS CANIS; STREPTOCOCCUS DYSGALACTIAE; STREPTOCOCCUS EQUI; STREPTOCOCCUS GALLOLYTICUS; STREPTOCOCCUS INIAE; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PORCINUS; STREPTOCOCCUS SUIS; STREPTOCOCCUS UBERIS;

ANIMALS; CATTLE; EXTRACELLULAR SPACE; HORSE DISEASES; HORSES; MASTITIS, BOVINE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; SWINE; SWINE DISEASES; VIRULENCE FACTORS;

EID: 2442713060     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1287     Document Type: Review

References (270)

1. Facklam R.: What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin Microbiol Rev 15, 613-630 (2002)
2. Poyart C., G. Quesne, S. Coulon, P. Berche & P. Trieu-Cuot: Identification of Streptococci to species level by sequencing the gene encoding the manganese-dependent superoxide dismutase. J Clin Microbiol 36, 41-47 (1998)
3. Bentley R. W., J. A. Leigh & M. D. Collins: Intrageneric structure of Streptococcus based on comparative analysis of small-subunit rRNA sequences. Int J Syst Bacteriol 41, 487-494 (1991)
4. Navarre W. W. & O. Schneewind: Surface proteins of Gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol Mol Biol Rev 63, 174-229 (1999)
5. Collin M. & A. Olsén: Generation of a mature streptococcal cysteine proteinase is dependent on cell wall-anchored M1 protein. Mol Microbiol 36, 1306-1318 (2000)
6. Berge A. & L. Björck: Streptococcal cysteine proteinase releases biologically active fragments of streptococcal surface proteins. J Biol Chem 270, 9862-9867 (1995)
7. Higgins R. & M. Gottschalk: Streptococcal diseases. In: Diseases of swine. Eds: Straw B E, D'Allaire S, Mengeling W L, Taylor D J, Iowa State University, Ames (1999)
8. Reams R. Y., D. D. Harrington, L. T. Glickman, H. L. Thacker & T. L. Bowersock: Multiple serotypes and strains of Streptococcus suis in naturally infected swine herds. J Vet Diagn Invest 8, 119-121 (1996)
9. Salasia S. I., C. Lammler & L. A. Devriese: Serotypes and putative virulence markers of Streptococcus suis isolates from cats and dogs. Res Vet Sci 57, 259-261 (1994)
10. Cruz Colque J. I., L. A. Devriese & F. Haesebrouck: Streptococci and enterococci associated with tonsils of cattle. Lett Appl Microbiol 16, 72-74 (1993)
11. Higgins R., A. Lagace, S. Messier & L. Julien: Isolation of Streptococcus suis from a young wild boar. Can Vet J 38, 114 (1997)
12. Perch B., K. B. Pedersen & J. Henrichsen: Serology of capsulated streptococci pathogenic for pigs: six new serotypes of Streptococcus suis. J Clin Microbiol 17, 993-996 (1983)
13. Higgins R. & M. Gottschalk: An update on Streptococcus suis identification. J Vet Diagn Invest 2, 249-252 (1990)
14. Gottschalk M. & M. Segura: The pathogenesis of the meningitis caused by Streptococcus suis: the unresolved questions. Vet Microbiol, 75, 59-71 (2000)
15. Williams A. E. & W. F. Blakemore: Pathogenesis of meningitis caused by Streptococcus suis type 2. J Infect Dis 162, 474-481 (1990)
16. Moxon E. R. & J. S. Kroll: The role of bacterial polysaccharide capsules as virulence factors. Curr Top Microbiol Immunol 150, 65-85 (1990)
17. Jacques M., M. Gottschalk, B. Foiry & R. Higgins: Ultrastructural study of surface components of Streptococcus suis. J Bacteriol 172, 2833-2838 (1990)
18. Elliott S. D. & J. Y. Tai: The type-specific polysaccharides of Streptococcus suis. J Exp Med 148, 1699-1704 (1978)
19. Katsumi M., T. Saito, Y. Kataoka, T. Itoh, N. Kikuchi & T. Hiramune: Comparative preparation methods of sialylated capsule antigen from Streptococcus suis type 2 with type specific antigenicity. J Vet Med Sci 58, 947-952 (1996)
20. Charland N., J. T. Kellens, F. Caya & M. Gottschalk: Agglutination of Streptococcus suis by sialic acid-binding lectins. J Clin Microbiol 33, 2220-2221 (1995)
21. Charland N., M. Jacques, S. Lacouture & M. Gottschalk: Characterization and protective activity of a monoclonal antibody against a capsular epitope shared by Streptococcus suis serotypes 1, 2 and 1/2. Microbiology 143, 3607-3614 (1997)
22. Elliott S. D., F. Clifton-Hadley & J. Tai: Streptococcal infection in young pigs. V. An immunogenic polysaccharide from Streptococcus suis type 2 with particular reference to vaccination against streptococcal meningitis in pigs. J Hyg Lond 85, 275-285 (1980)
23. del Campo Sepulveda E. M., E. Altman, M. Kobisch, S. D'Allaire & M. Gottschalk: Detection of antibodies against Streptococcus suis capsular type 2 using a purified capsular polysaccharide antigen-based indirect ELISA. Vet Microbiol 52, 113-125 (1996)
24. Agarwal K. K., S. D. Elliott & P. J. Lachmann: Streptococcal infection in young pigs. III. The immunity of adult pigs investigated by the bactericidal test. J Hyg 67, 491-503 (1969)
25. Charland N., J. Harel, M. Kobish, S. Lacasse & M. Gottschalk: Streptococcus suis serotype 2 mutants deficient in capsular expression. Microbiology 144, 325-332 (1998)
26. Smith H. E., M. Damman, J. Van der Velde, F. Wagenaar, H. J. Wisselink, N. Stockhofe-Zurwieden & M. A. Smits: Identification and characterization of the cps locus of Streptococcus suis serotype 2: the capsule protects against phagocytosis and is an important virulence factor. Infect Immun 67, 1750-1756 (1999)
27. Gottschalk M., S. Petitbois, R. Higgins & M. Jacques: Adherence of Streptococcus suis capsular type 2 to porcine lung sections. Can J Vet Res 55, 302-304 (1991)
28. Quessy S., J. D. Dubreuil, M. Jacques, F. Malouin & R. Higgins: Increase of capsular material thickness following in vivo growth of virulent Streptococcus suis serotype 2 strains. FEMS Microbiol Lett 115, 19-26 (1994)
29. Wessels M. R., C. E. Rubens, V. J. Benedi & D. L. Kasper: Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule. Proc Natl Acad Sci USA 86, 8983-8987 (1989)
30. Charland N., M. Kobisch, B. Martineau-Doize, M. Jacques & M. Gottschalk: Role of capsular sialic acid in virulence and resistance to phagocytosis of Streptococcus suis capsular type 2. FEMS Immunol Med Microbiol 14, 195-203 (1996)
31. Gottschalk M., R. Higgins, M. Jacques, M. Beaudoin & J. Henrichsen: Isolation and characterization of Streptococcus suis capsular types 9-22. J Vet Diagn Invest 3, 60-65 (1991)
32. Robertson I. D., D. K. Blackmore, D. J. Hampson & Z. F. Fu: A longitudinal study of natural infection of piglets with Streptococcus suis types 1 and 2. Epidemiol Infect 107, 119-126 (1991)
33. Vecht U., H. J. Wisselink, M. L. Jellema & H. E. Smith: Identification of two proteins associated with virulence of Streptococcus suis type 2. Infect Immun 59, 3156-3162 (1991)
34. Vecht U., J. P. Arends, E. J. van der Molen & L. A. van Leengoed: Differences in virulence between two strains of Streptococcus suis type II after experimentally induced infection of newborn germ-free pigs. Am J Vet Res 50, 1037-1043 (1989)
35. Vecht U., H. J. Wisselink, J. E. van Dijk & H. E. Smith: Virulence of Streptococcus suis type 2 strains in newborn germfree pigs depends on phenotype. Infect Immun 60, 550-556 (1992)
36. Smith H. E., F. H. Reek, U. Vecht, A. L. Gielkens & M. A. Smits: Repeats in an extracellular protein of weakly pathogenic strains of Streptococcus suis type 2 are absent in pathogenic strains. Infect Immun 61, 3318-3326 (1993)
37. Wisselink H. J., H. E. Smith, N. Stockhofe-Zurwieden, K. Peperkamp & U. Vecht: Distribution of capsular types and production of muramidase-released protein (MRP) and extracellular factor (EF) of Streptococcus suis strains isolated from diseased pigs in seven European countries. Vet Microbiol 74, 237-248 (2000)
38. Gottschalk M., A. Lebrun, H. Wisselink, J. D. Dubreuil, H. Smith & U. Vecht: Production of virulence-related proteins by Canadian strains of Streptococcus suis capsular type 2. Can J Vet Res 62, 75-79 (1998)
39. Smith H. E., U. Vecht, A. L. Gielkens & M. A. Smits: Cloning and nucleotide sequence of the gene encoding the 136-kilodalton surface protein (muramidase-released protein) of Streptococcus suis type 2. Infect Immun 60, 2361-2367 (1992)
40. Smith H. E., U. Vecht, H. J. Wisselink, N. Stockhofe-Zurwieden, Y. Biermann & M. A. Smits: Mutants of Streptococcus suis types 1 and 2 impaired in expression of muramidase-released protein and extracellular protein induce disease in newborn germfree pigs. Infect Immun 64, 4409-4412 (1996)
41. Chatellier S., M. Gottschalk, R. Higgins, R. Brousseau & J. Harel: Relatedness of Streptococcus suis serotype 2 isolates from different geographic origins as evaluated by molecular fingerprinting and phenotyping. J Clin Microbiol 37, 362-366 (1999)
42. Wisselink H. J., U. Vecht, N. Stockhofe-Zurwieden & H. E. Smith: Protection of pigs against challenge with virulent Streptococcus suis serotype 2 strains by a muramidase-released protein and extracellular factor vaccine. Vet Rec 148, 473-477 (2001)
43. Berthelot-Hérault F., H. Morvan, A.-M. Kéribin, M. Gottschalk & M. Kobisch: Production of muraminidase-released protein (MRP), extracellular factor (EF) and suilysin by field isolates of Streptococcus suis capsular types 2, 1/2, 9, 7 and 3 isolated from swine in France. Vet Res 31, 473-479 (2000)
44. Galina L., U. Vecht, H. J. Wisselink & C. Pijoan: Prevalence of various phenotypes of Streptococcus suis isolated from swine in the U.S.A. based on the presence of muraminidase-released protein and extracellular factor. Can J Vet Res 60, 72-74 (1996)
45. Jacobs A. A., P. L. Loeffen, A. J. van den Berg & P. K. Storm: Identification, purification, and characterization of a thiol-activated hemolysin (suilysin) of Streptococcus suis. Infect Immun 62, 1742-1748 (1994)
46. Gottschalk M. G., S. Lacouture & J. D. Dubreuil: Characterization of Streptococcus suis capsular type 2 haemolysin. Microbiology 141, 189-195 (1995)
47. Palmer M.: The family of thiol-activated, cholesterol-binding cytolysins. Toxicon 39, 1681-1689 (2001)
48. Alouf J. E. & C. Geoffroy: The family of the antigenically-related cholesterol-binding ("sulphydryl-activated") cytolytic toxins. In: Sourcebook of Bacterial Protein Toxins. Eds: Alouf J E, New York Academic Press, New York (1991)
49. Segers R. P., T. Kenter, L. A. M. de Haan & A. A. C. Jacobs: Characterisation of the gene encoding suilysin from Streptococcus suis and expression in field strains. FEMS Microbiol Lett 167, 255-261 (1998)
50. Feder I., M. M. Chengappa, B. Fenwick, M. Rider & J. Staats: Partial characterization of Streptococcus suis type 2 hemolysin. J Clin Microbiol 32, 1256-1260 (1994)
51. Charland N., V. Nizet, C. Rubens, K. S. Kim, S. Lacouture & M. Gottschalk: Streptococcus suis serotype 2 interactions with human brain microvascular endothelial cells. Infect Immun 68, 637-643 (2000)
52. Lalonde M., M. Segura, S. Lacouture & M. Gottschalk: Interactions between Streptococcus suis serotype 2 and different epithelial cell lines. Microbiology 146, 1913-1921 (2000)
53. Norton P. M., C. Rolph, P. N. Ward, R. W. Bentley & J. A. Leigh: Epithelial invasion and cell lysis by virulent strains of Streptococcus suis is enhanced by the presence of suilysin. FEMS Immunol Med Microbiol 26, 25-35 (1999)
54. Segura M. & M. Gottschalk: Streptococcus suis interactions with the murine macrophage cell line J774: adhesion and cytotoxicity. Infect immun 70, 4312-4322 (2002)
55. Vadeboncoeur N., M. Segura, D. Al-Numani, G. Vanier & M. Gottschalk: Pro-inflammatory cytokine and chemokine release by human brain microvascular endothelial cells stimulated by Streptococcus suis serotype 2. FEMS Immunol Med Microbiol 35, 49-58 (2003)
56. Lun S., J. Perez-Casal, W. Connor & P. J. Willson: Role of suilysin in pathogenesis of Streptococcus suis capsular serotype 2. Microb Pathog 34, 27-37 (2003)
57. Al-Numani D., M. Segura, M. Doré & M. Gottschalk: Up-regulation of ICAM-1, CD11a/CD18 and CD11c/CD18 on human THP-I monocytes stimulated by Streptococcus suis serotype 2. Clin Exp Immunol 133, 67-77 (2002)
58. Allen A. G., S. Bolitho, H. Lindsay, S. Khan, C. Bryant, P. M. Norton, P. N. Ward, J. A. Leigh, J. Morgan, H. Riches, S. Eastty & D. Maskell: Generation and characterization of a defined mutant of Streptococcus suis lacking suilysin. Infect Immun 69, 2732-2735 (2001)
59. Jacobs A. A., A. J. van den Berg & P. L. Loeffen: Protection of experimentally infected pigs by suilysin, the thiol-activated haemolysin of Streptococcus suis. Vet Rec 139, 225-228 (1996)
60. Jacobs A. A., A. J. van den Berg, J. C. Baars, B. Nielsen & L. W. Johannsen: Production of suilysin, the thiol-activated haemolysin of Streptococcus suis, by field isolates from diseased pigs. Vet Rec 137, 295-296 (1995)
61. Okwumabua O., O. Abdelmagid & M. M. Chengappa: Hybridization analysis of the gene encoding a hemolysin (suilysin) of Streptococcus suis type 2: evidence for the absence of the gene in some isolates. FEMS Microbiol Lett 181, 113-121 (1999)
62. Staats J., P. Brandon, G. Stewart & M. M. Chengappa: Presence of the Streptococcus suis suilysin gene and expression of MRP and EF correlates with high virulence in Streptococcus suis type 2 isolates. Vet Microbiol 70, 201-211 (1999)
63. Allgaier A., R. Goethe, H. J. Wisselink, H. E. Smith & P. Valentin-Weigand: Relatedness of Streptococcus suis isolates of various serotypes and clinical backgrounds as evaluated by macrorestriction analysis and expression of potential virulence traits. J Clin Microbiol 39, 445-453 (2001)
64. Hommez J., L. A. Devriese, F. Castryck & C. Miry: Beta-hemolytic streptococci from pigs: bacteriological diagnosis. J Vet Med B 38, 441-444 (1991)
65. Yamaguchi M., M. Miyake, H. Nishiya & M. Noda: A cytotoxic factor of Streptococcus suis isolated from a septicemia patient. Jpn J Med Sci Biol 47, 318-319 (1994)
66. Jobin M.-C. & D. Grenier: Identification and characterization of four proteases produced by Streptococcus suis. FEMS Microbiol Lett 220, 113-119 (2003)
67. Mentlein R.: Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides. Regul Pept 85, 9-24 (1999)
68. Langford P., A. E. Williams & J. S. Kroll: Superoxide dismutases of pathogenic and non-pathogenic Streptococcus suis type 2 isolates. FEMS Microbiol Lett 61, 347-350 (1991)
69. Niven D. F., A. Ekins & A. A. W. Al-Samaurai: Effects of iron and manganese availability on growth and production of Superoxide dismutase by Streptococcus suis. Can J Microbiol 45, 1027-1032 (1999)
70. Beachey E. H.: Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surfaces. J Infect Dis 143, 325-345 (1981)
71. Gottschalk M., A. Lebrun, M. Jacques & R. Higgins: Hemagglutination properties of Streptococcus suis. J Clin Microbiol 28, 2156-2158 (1990)
72. Jack R. W., J. R. Tagg & B. Ray: Bacteriocins of gram-positive bacteria. Microbiol Rev 59, 171-200 (1995)
73. Mélançon D. & D. Grenier: Production and properties of bacteriocin-like inhibitory substances from the swine pathogen Streptococcus suis serotype 2. Appl Environ Microbiol 69, 4482-4488 (2003)
74. Wessman G. E.: Biology of the group E streptococci: a review. Vet Microbiol 12, 297-328 (1986)
75. Laminler C., N. Cirak & J. Smola: Studies on biochemical, serological and further characteristics of Streptococcus porcinus. J Vet Med B 45, 235-243 (1998)
76. Facklam R., J. Elliott, N. Pigott & A. R. Franklin: Identification of Streptococcus porcinus from human sources. J Clin Microbiol 33, 385-388 (1995)
77. Kim D. M., S. J. Lee, S. K. Yoon & S. M. Byun: Specificity role of the streptokinase C-terminal domain in plasminogen activation. Biochem Biophys Res Commun 290, 585-588 (2002)
78. Lahteenmaki K., P. Kuusela & T. K. Korhonen: Bacterial plasminogen activators and receptors. FEMS Microbiol Rev 25, 531-552 (2001)
79. Katsumi M., Y. Kataoka, T. Takahashi, N. Kikuchi & T. Hiramune: Biochemical and serological examination of beta-hemolytic streptococci isolated from slaughtered pigs. J Vet Med Sci 60, 129-131 (1998)
80. Schofield C. R. & J. R. Tagg: Bacteriocin-like activity of group B and group C streptococci of human and of animal origin. J Hyg (Lond) 90, 7-18 (1983)
81. Dierksen K. P. & J. R. Tagg: Haemolysin-deficient variants of Streptococcus pyogenes and S. dysgalactiae subsp. equisimilis may be overlooked as aetiological agents of pharyngitis. J Med Microbiol 49, 811-816 (2000)
82. Gerlach D., W. Kohler, E. Gunther & K. Mann: Purification and characterization of streptolysin O secreted by Streptococcus equisimilis (group C). Infect Immun 61, 2727-2731 (1993)
83. Bisno A. L., C. Collins & J. C. Turner: M proteins of Streptococcus equisimilis strains isolated from pharyngitis patients. Adv Exp Med Biol 418, 745-748 (1997)
84. Sachse S., P. Seidel, D. Gerlach, E. Gunther, J. Rodel, E. Straube & K. H. Schmidt: Superantigen-like gene(s) in human pathogenic Streptococcus dysgalactiae, subsp equisimilis: genomic localisation of the gene encoding streptococcal pyrogenic exotoxin G (speG(dys)). FEMS Immunol Med Microbiol 34, 159-167 (2002)
85. McCoy H. E., C. C. Broder & R. Lottenberg: Streptokinases produced by pathogenic group C streptococci demonstrate species specificity plasminogen activation. J Infect Dis 164, 515-521 (1991)
86. Caballero A. R., R. Lottenberg & K. H. Johnston: Cloning, expression, sequence analysis, and characterization of streptokinases secreted by porcine and equine isolates of Streptococcus equisimilis. Infect Immun 67, 6478-6486 (1999)
87. Schroeder B., M. D. P. Boyle, B. R. Sheerin, A. C. Asbury & R. Lottenberg: Species specificity of plasminogen activation and acquisition of surface-associated proteolytic activity by Group C Streptococci grown in plasma. Infect Immun 67, 6487-6495 (1999)
88. Nowicki S. T., D. Minning-Wenz, K. H. Johnston & R. Lottenberg: Characterization of a novel streptokinase produced by Streptococcus equisimilis of non-human origin. Thromb Haemost 72, 595-603 (1994)
89. Fox L. K. & J. M. Gay: Contagious mastitis. Vet Clin Norht Am Food Anim Pract 9, 475-487 (1993)
90. Calvinho L. F., R. A. Almeida & S. P. Oliver: Potential virulence factors of Streptococcus dysgalactiae associated with bovine mastitis. Vet Microbiol 61, 93-110 (1998)
91. Calvinho L. F., R. A. Almeida & S. P. Oliver: Influence of Streptococcus dysgalactiae surface hydrophobicity on adherence to mammary epithelial cells and phagocytosis by mammary macrophages. Zentralbl Veterinarmed [B] 43, 257-266 (1996)
92. Fishetti V. A.: Streptococcal M proteins. Sci Am 264, 32-39 (1991)
93. Mamo W., G. Fröman, A. Sundås & T. Wadström: Binding of fibronectin, fibrinogen and type 11 collagen to streptococci isolated from bovine mastitis. Microb Pathog 2, 417-424 (1987)
94. Rantamäki L. K. & H. P. Müller: Phenotypic characterization of Streptococcus dysgalactiae isolates from bovine mastitis by their binding to host derived proteins. Vet Microbiol 46, 415-426 (1995)
95. Vasi J., L. Frykberg, L. E. Carlsson, M. Lindberg & B. Guss: M-like proteins of Streptococcus dysgalactiae. Infect Immun 68, 294-302 (2000)
96. Traore M. Y., P. Valentin-Weigand, G. S. Chhatwal & H. Blobel: Inhibitory effects of fibrinogen on phagocytic killing of streptococcal isolates from humans, cattle and horses. Vet Microbiol 28, 295-302 (1991)
97. Vandamme P., B. Pot, E. Falsen, K. Kersters & L. A. Devriese: Taxonomic study of Lancefield streptococcal groups C, G, and L (Streptococcus dysgalactiae) and proposal of S. dysgalactiae subsp. equisimilis subsp. nov. Int J Syst Bacterial 46, 774-781 (1996)
98. Leigh J. A., S. M. Hodgkindson & R. A. Lincoln: The interaction of Streptococcus dysgalactiae with plasmin and plasminogen. Vet Microbiol 61, 121-135 (1998)
99. Sting R., P. Schaufuss & H. Blobel: Isolation and characterization of hyaluronidases from Streptococcus dysgalactiae, S. zooepidemicus and S. equi. Zentralbl Bakteriol 272, 276-282 (1990)
100. Miyoshi-Akiyama T., J. Zhao, H. Kato, K. Kikuchi, K. Totsuka, Y. Kataoka, M. Katsumi & T. Uchiyama: Streptococcus dysgalactiae-denved mitogen (SDM), a novel bacterial superantigen: characterization of its biological activity and predicted tertiary structure. Mol Microbiol 47, 1589-1599 (2003)
101. Leigh J. A.: Streptococcus uberis: a permanent barrier to the control of bovine mastitis? Vet J 157, 225-238 (1999)
102. Vaarst M. & C. Enevoldsen: Patterns of clinical mastitis manifestations in Danish organic dairy herds. J Dairy Res 64, 23-37 (1997)
103. Thomas L. H., W. Haider, A. W. Hill & R. S. Cook: Pathologic findings of experimentally induced Streptococcus uberis infection in the mammary gland of cows. Am J Vet Res 55, 1723-1728 (1994)
104. Oliver S. P., R. A. Almeida & L. F. Calvinho: Virulence factors of Streptococcus uberis isolated from cows with mastitis. Zentralbl Veterinarmed [B] 45, 461-471 (1998)
105. Hill A. W.: Pathogenicity of two strains of Streptococcus uberis infused into lactating and non-lactating bovine mammary glands. Res Vet Sci 45, 400-404 (1988)
106. Leigh J. A., T. R. Field & M. R. Williams: Two strains of Streptococcus uberis, of differing ability to cause clinical mastitis, differ in their ability to resist some host defence factors. Res Vet Sci 49, 85-87 (1990)
107. Leigh J. A. & T. R. Field: Streptococcus uberis resists the bactericidal action of bovine neutrophils despite the presence of bound immunoglobulin. Infect Immun 62, 1854-1859 (1994)
108. Almeida R. A. & S. P. Oliver: Growth curve, capsule expression and characterization of the capsular material of selected strains of Streptococcus uberis. Zentralbl Veterinarmed [B] 40, 697-706 (1993)
109. Leigh J. A. & T. R. Field: Killing of Streptococcus uberis by bovine neutrophils following growth in chemically defined media. Vet Res Commun 15, 1-6 (1991)
110. Ward P. N., T. R. Field, W. G. Ditcham, E. Maguin & J. A. Leigh: Identification and disruption of two discrete loci encoding hyaluronic acid capsule biosynthesis genes hasA, hasB, and hasC in Streptococcus uberis. Infect Immun 69, 392-399 (2001)
111. Ashbaugh C. D., S. Alberti & M. R. Wessels: Molecular analysis of the capsule gene region of group A Streptococcus: the hasAB genes are sufficient for capsule expression. J Bacteriol 190, 4955-4959 (1998)
112. Almeida R. A. & S. P. Oliver: Antiphagocytic effect of the capsule of Streptococcus uberis. Zentralbl Veterinarmed [B] 40, 707-714 (1993)
113. Almeida R. A. & S. P. Oliver: Phagocytosis of Streptococcus uberis by bovine mammary macrophages:opsonizing effect of bovine antiserum. Zentralbl Veterinarmed [B] 42, 331-337 (1995)
114. Grant R. G. & J. M. Finch: Phagocytosis of Streptococcus uberis by bovine mammary gland macrophages. Res Vet Sci 62, 74-78 (1996)
115. Field T. R., P. N. Ward, L. H. Pedersen & J. A. Leigh: The hyaluronic acid capsule of Streptococcus uberis is not required for the development of infection and clinical mastitis. Infect Immun 71, 132-139 (2003)
116. Leigh J. A.: Activation of bovine plasminogen by Streptococcus uberis. FEMS Microbiol Lett 114, 67-71 (1993)
117. Leigh J. A.: Purification of a plasminogen activator from Streptococcus uberis. FEMS Microbiol Lett 118, 153-158 (1994)
118. Lincoln R. A. & J. A. Leigh: Characterization of a novel plasminogen activator from Streptococcus uberis. Adv Exp Med Biol 418, 643-645 (1997)
119. Johnsen L. B., K. Poulsen, M. Kilian & T. E. Petersen: Purification and cloning of a streptokinase from Streptococcus uberis. Infect Immun 67, 1072-1078 (1999)
120. Rosey E. L., R. A. Lincoln, P. N. Ward, R. J. J. Yancey & J. A. Leigh: PauA: a novel plasminogen activator from Streptococcus uberis. FEMS Microbiol Lett 178, 27-33 (1999)
121. Sazonova I. Y., A. K. Houng, S. A. Chowdhry, B. R. Robinson, L. Hedstrom & G. L. Reed: The mechanism of a bacterial plasminogen activator intermediate between streptokinase and staphylokinase. J Biol Chem 276, 12609-12613 (2001)
122. Johnsen L. B., L. K. Rasmussen, T. E. Petersen, M. Etzerodt & S. N. Fedosov: Kinetic and structural characterization of a two-domain streptokinase: dissection of domain functionality. Biochemistry 39, 6440-6448 (2000)
123. Ward P. N. & J. A. Leigh: Characterization of PauB, a novel broad-spectrum plasminogen activator from Streptococcus uberis. J Bacteriol 184, 119-125 (2002)
124. Leigh J. A. & R. A. Lincoln: Streptococcus uberis acquires plasmin activity following growth in the presence of bovine plasminogen through the action of its specific plasminogen activator. FEMS Microbiol Lett 154, 123-129 (1997)
125. Kitt A. J. & J. A. Leigh: The auxotrophic nature of Streptococcus uberis. The acquisition of essential acids from plasmin derived casein peptides. Adv Exp Med Biol 418, 647-650 (1997)
126. Schaufuss P., R. Sting, W. Schaeg & H. Blobel: Isolation and characterization of hyaluronidase from Streptococcus uberis. Zentralbl Bakteriol 271, 46-53 (1989)
127. Matthews K. R., J. J. Rejman, J. D. Turner & S. P. Oliver: Proliferation of a bovine mammary epithelial cell line in the presence of bacterial virulence factors. J Dairy Sci 77, 2959-2964 (1994)
128. Lammler C.: Biochemical and serological properties of Streptococcus uberis. Zentralbl Veterinarmed [B] 38, 737-742 (1991)
129. Lopes M. F., V. L. Merquior, J. M. Peralta & L. M. Teixeira: Partial characterization of the cohemolytic factor produced by Streptococcus uberis and comparison with the CAMP-factor. FEMS Immunol Med Microbiol 12, 205-212 (1995)
130. Hassan A. A., A. Abdulmawjood, A. O. Yildirim, K. Fink, C. Lammler & R. Schlenstedt: Identification of streptococci isolated from various sources by determination of cfb gene and other CAMP-factor genes. Can J Microbiol 46, 946-951 (2000)
131. Jiang M., L. A. Babiuk & A. A. Potter: Cloning, sequencing and expression of the CAMP factor gene of Streptococcus uberis. Microb Pathog 20, 297-307 (1996)
132. Shalka B. & J. Smola: Lethal effect of CAMP-factor and Uberis-factor: a new finding about diffusible exosubstances of Streptococcus agalactiae and Streptococcus uberis. Zentralbl Bakteriol 249, 190-194 (1981)
133. Fang W., D. A. Luther & S. P. Olivier: Protein expression by Streptococcus uberis in co-culture with bovine mammary epithelial cells. FEMS Microbiol Lett 166, 237-242 (1998)
134. Gilbert F. B., D. A. Luther & S. P. Olivier: Induction of surface-associated proteins of Streptococcus uberis by cultivation with extracellular matrix components and bovine mammary epithelial cells. FEMS Microbiol Lett 156, 161-164 (1997)
135. Manning S. D.: Molecular epidemiology of Streptococcus agalactiae (group B Streptococcus). Front Biosci 8, S1-18 (2003)
136. Spellerberg B.: Pathogenesis of neonatal Streptococcus agalactiae infections. Microbes Infect 2, 1733-1742 (2000)
137. Keefe G. P.: Streptococcus agalactiae mastitis: a review. Can Vet J 38, 429-437 (1997)
138. Eldar A., Y. Bejerano, A. Livoff, A. Horovitcz & H. Bercovier: Experimental streptococcal meningoencephalitis in cultured fish. Vet Microbiol 43, 33-40 (1995)
139. Vandamme P., L. A. Devriese, B. Pot, K. Kersters & P. Melin: Streptococcus difficile is a nonhemolytic group B, type Ib Streptococcus. Int J Syst Bacteriol 47, 81-85 (1997)
140. Geyer A., A. Roth, S. Vettermann, E. Gunther, A. Groh, E. Straube & K. Schmidt: M protein of a Streptococcus dysgalactiae human wound isolate shows multiple binding to different plasma proteins and shares epitopes with keratin and human cartilage. FEMS Immunol Med Microbiol 26, 11-24 (1999)
141. Yildirim A. O., C. Lammler, R. Weiss & P. Kopp: Pheno- and genotypic properties of streptococci of serological group B of canine and feline origin. FEMS Microbiol Lett 212, 187-192 (2002)
142. Poutrel B. & J. Dore: Virulence of human and bovine isolates of group B streptococci (types Ia and III) in experimental pregnant mouse models. Infect Immun 47, 94-97 (1985)
143. Finch L. A. & D. R. Martin: Human and bovine group B streptococci: two distinct populations. J Appl Bacteriol 57, 273-278 (1984)
144. Klegerman M. E., K. M. Boyer, C. K. Papierniak, L. Levine & S. P. Gotoff: Type-specific capsular antigen is associated with virulence in late-onset group B streptococcal type III disease. Infect Immun 44, 124-129 (1984)
145. Martinez G., J. Harel, R. Higgins, S. Lacouture, D. Daignault & M. Gottschalk: Characterization of Streptococcus agalactiae isolates of bovine and human origin by randomly amplified polymorphic DNA analysis. J Clin Microbiol 38, 71-78 (2000)
146. Segura M. A., P. Cléroux & M. Gottschalk: Streptococcus suis and group B Streptococcus differ in their interactions with murine macrophages. FEMS Immunol Med Microbiol 21, 189-195 (1998)
147. Rubens C. E., M. R. Wessels, L. M. Heggen & D. L. Kasper: Transposon mutagenesis of group B streptococcal type III capsular polysaccharide: correlation of capsule expression with virulence. Proc Natl Acad Sci USA 84, 7208-7212 (1987)
148. Rainard P., Y. Lautrou & B. Poutrel: Ingestion and killing of Streptococcus agalactiae by bovine granulocytes in the presence of natural opsonins. Vet Microbiol 18, 41-50 (1988)
149. Salasia S. I., I. W. Wibawan, C. Lammler & M. Sellin: Phase variation in streptococci of serological group B. Characteristic properties of isolates from human and bovine infection. APMIS 102, 925-930 (1994)
150. Platt M. W.: In vivo hemolytic activity of group B Streptococcus is dependent on erythrocyte-bacteria contact and independent of a carrier molecule. Curr Microbiol 31, 5-9 (1995)
151. Dal M. C. & H. Monteil: Hemolysin produced by group B Streptococcus agalactiae. FEMS Microbiol Lett 16, 89-94 (1983)
152. Spellerberg B., B. Pohl, G. Haase, S. Martin, J. Weber-Heynemann & R. Lutticken: Identification of genetic determinants for the hemolytic activity of Streptococcus agalactiae by ISS1 transposition. J Bacteriol 181, 3212-3219 (1999)
153. Spellerberg B., S. Martin, C. Brandt & R. Lutticken: The cyl genes of Streptococcus agalactiae are involved in the production of pigment. FEMS Microbiol Lett 188, 125-128 (2000)
154. Griffiths B. B.: Kinetics of hemolysin production in bovine group B streptococci. J Basic Microbiol 30, 241-250 (1990)
155. Schlievert P. M., J. E. Gocke & J. R. Deringer: Group B streptococcal toxic shock-like syndrome: report of a case and purification of an associated pyrogenic toxin. Clin Infect Dis 17, 26-31 (1993)
156. Sundell H. W., H. Yan, C. E. Carter, B. D. Wamil, K. Wu, R. Gaddipati, D. Li & C. G. Hellerqvist: Isolation and identification of the group B streptococcal toxin CM101 from infants with sepsis. J Pediatr 137, 338-344 (2000)
157. Pritchard D. G. & B. Lin: Group B streptococcal neuraminidase is actually a hyaluronidase. Infect Immun 61, 3234-3239 (1993)
158. Ozegowski J. H., E. Gunther & W. Reichardt: Purification and characterization of hyaluronidase from Streptococcus agalactiae. Zentralbl Bakteriol 280, 497-506 (1994)
159. Lin B., S. K. Hollingshead, J. E. Coligan, M. L. Egan, J. R. Baker & D. G. Pritchard: Cloning and expression of the gene for Group B Streptococcal hyaluronate lyase. J Biol Chem 269, 30113-30116 (1994)
160. Haug R. H., O. Olsvik & O. Hushovd: Hyaluronidase production, lactose and salicin fermentation and phagetypability in bovine group B Streptococci. NIPH Ann 4, 69-73 (1981)
161. Yildirim A. O., C. Lammler & R. Weiss: Identification and characterization of Streptococcus agalactiae isolated from horses. Vet Microbiol 85, 31-35 (2002)
162. Pritchard D. G., B. Lin, T. R. Willingham & J. R. Baker: Characterization of the group B streptococcal hyaluronate lyase. Arch Biochem Biophys 315, 431-437 (1994)
163. Mello L. V., B. L. De Groot, S. Li & M. J. Jedrzejas: Structure and flexibility of Streptococcus agalactiae hyaluronate lyase complex with its substrate. Insights into the mechanism of processive degradation of hyaluronan. J Biol Chem 277, 36678-36688 (2002)
164. Li S. & M. J. Jedrzejas: Hyaluronan binding and degradation by Streptococcus agalactiae hyaluronate lyase. J Biol Chem 276, 41407-41416 (2001)
165. Orefici G., A. De Stasio, M. Guarino, A. Martini & N. Orsi: Group B streptococci: extracellular neuraminidase production and virulence in mouse. Microbiologica 7, 75-78 (1984)
166. Podbielski A., O. Blankenstein & R. Lutticken: Molecular characterization of the cfb gene encoding group B streptococcal CAMP-factor. Med Microbiol Immunol (Berl) 183, 239-256 (1994)
167. Hassan A. A., O. Akineden, C. Lammler & R. Huber-Schlenstedt: Molecular characterization of phenotypically CAMP-negative Streptococcus agalactiae isolated from bovine mastitis. J Vet Med B 49, 257-259 (2002)
168. Jurgens D., B. Sterzik & F. J. Fehrenbach: Unspecific binding of group B streptococcal cocytolysin (CAMP factor) to immunoglobulins and its possible role in pathogenicity. J Exp Med 165, 720-732 (1987)
169. Fehrenbach F. J., D. Jurgens, J. Ruhlmann, B. Sterzik & M. Ozel: Role of CAMP-factor (factor B) for virulence. Zentbl Bakteriol Hyg Suppl 17, 351-357 (1988)
170. Lang S. & M. Palmer: Characterization of Streptococcus agalactiae CAMP factor as a pore-forming toxin. J Biol Chem June 30, [Epub ahead of print] (2003)
171. Caillot O., C. Poyart, P. Berche & P. Trieu-Cuot: Molecular characterization and expression analysis of the superoxide dismutase gene from Streptococcus agalacliae. Gene 204, 213-218 (1997)
172. Valentin-Weigand P., P. Benkel, M. Rohde & G. S. Chhatwal: Entry and intracellular survival of group B Streptococci in J774 macrophages. Infect Immun 64, 2467-2473 (1996)
173. Poyart C., E. Pellegrini, O. Caillot, C. Boumaila, M. Baptista & P. Trieu-Cuot: Contribution of Mn-cofactored superoxide dismutase (SodA) to the virulence of Streptococcus agalactiae. Infect Immun 69, 5098-5106 (2001)
174. Barnham M., A. Ljunggren & M. McIntyre: Human infection with Streptococcus zooepidemicus (Lancefield group C): three case reports. Epidemiol Infect 98, 183-190 (1987)
175. Boucher C., R. Higgins, M. Nadeau & C. Vincent: [A case of zoonosis associated with Streptococcus equi ssp. zooepidemicus]. Can Vet J 43, 123-124 (2002)
176. Lindmark H., P. Jonsson, E. Engvall & B. Guss: Pulsed-field gel electrophoresis and distribution of the genes zag and fnz in isolates of Streptococcus equi. Res Vet Sci 66, 93-99 (1999)
177. Jorm L. R., D. N. Love, G. D. Bailey, G. M. Bailey & D. A. Briscoe: Genetic structure of populations of -haemolytic Lancefield group C streptococci from horses and their association with disease. Res Vet Sci 57, 292-299 (1994)
178. Chanter N.: Streptococci and enterococci as animal pathogens. J Appl Microbiol Symp Suppl 83, 100S-109S (1997)
179. Timoney J. F.: Strangles. Vet Clin North Am Equine Pract 9, 365-374 (1993)
180. Harrington D. J., I. C. Sutcliffe & N. Chanter: The molecular basis of Streptococcus equi infection and disease. Microbes Infect 4, 501-510 (2002)
181. Anzai T., J. Timoney, Y. Kuwamoto, Y. Fujita, R. Wada & T. Inoue: In vivo pathogenicity and resistance to phagocytosis of Streptococcus equi strains with different levels of capsule expression. Vet Microbiol 67, 277-286 (1999)
182. Srivastava S. K., D. A. Barnum & J. F. Prescott: Production and biological properties of M-protein of Streptococcus equi. Res Vet Sci 38, 184-188 (1985)
183. Walker J. & J. Timoney: Construction of a stable non-mucoid deletion mutant of the Streptococcus equi. Pinnacle vaccine strain. Vet Microbiol 89, 311 (2002)
184. Timoney J. & M. M. Mukhtar: The protective M proteins of the equine group C streptococci. Vet Microbiol 37, 389-395 (1993)
185. Chanter N., C. L. Ward, N. C. Collin, J. A. Flanagan, M. Binns, S. B. Houghton, K. C. Smith & J. A. Mumford: Recombinant hyaluronate associated protein as a protective immunogen against Streptococcus equi and Streptococcus zooepidemicus challenge in mice. Microb Pathog 27, 133-143 (1999)
186. Srivastava S. K. & D. A. Barnum: Adherence of Streptococcus equi on tongue, cheek and nasal epithelial cells of ponies. Vet Microbiol 8, 493-504 (1983)
187. Timoney J. F., S. C. Artiushin & J. S. Boschwitz: Comparison of the sequences and functions of Streptococcus equi M-like proteins SeM and SzPSe. Infect Immun 65, 3600-3605 (1997)
188. Meehan M., P. Nowlan & P. Owen: Affinity purification and characterization of a fibrinogen-binding protein complex which protects mice against lethal challenge with Streptococcus equi subsp. equi. Microbiology 144, 993-1003 (1998)
189. Meehan M., Y. Lynagh, C. Woods & P. Owen: The fibrinogen-binding protein of Streptococcus equi subsp. equi additionally binds IgG and contributes to virulence in a mouse model. Microbiology 147, 3311-3322 (2001)
190. Meehan M., D. A. Muldowney, N. J. Watkins & P. Owen: Localization and characterization of the ligand-binding domain of the fibrinogen-binding protein (FgBP) of Streptococcus equi subsp. equi. Microbiology 146, 1187-1194 (2000)
191. Boschwitz J. S. & J. F. Timoney: Characterization of the antiphagocytic activity of equine fibrinogen for Streptococcus equi subsp. equi. Microb Pathog 17, 121-129 (1994)
192. Boschwitz J. S. & J. F. Timoney: Inhibition of C3 deposition on Streptococcus equi subsp. equi by M protein: a mechanism for survival in equine blood. Infect Immun 62, 3515-3520 (1994)
193. Chanter N., N. C. Talbot, J. R. Newton, D. Hewson & K. Verheyen: Streptococcus equi with truncated M-proteins isolated from outwardly healthy horses. Microbiology 146, 1361-1369 (2000)
194. Lindmark H. & B. Guss: SFS, a novel fibronectin-binding protein from Streptococcus equi, inhibits the binding between fibronectin and collagen. Infect Immun 67, 2383-2388 (1999)
195. Lindmark H., M. Nilsson & B. Guss: Comparison of the fibronectin-binding protein FNE from Streptococcus equi subspecies equi with FNZ from S. equi subspecies zooepidemicus reveals a major and conserved difference. Infect Immun 69, 3159-3163 (2001)
196. Flanagan J., N. Collin, J. Timoney, T. Mitchell, J. A. Mumford & N. Chanter: Characterization of the haemolytic activity of Streptococcus equi. Microb Pathog 24, 211-221 (1998)
197. Anzai T., A. S. Sheoran, Y. Kuwamoto, T. Kondo, R. Wada, T. Inoue & J. Timoney: Streptococcus equi but not Streptococcus zooepidemicus produces potent mitogenic responses from equine peripheral blood mononuclear cells. Vet Immunol Immunopathol 67, 235-246 (1999)
198. Artiushin S. C., J. F. Timoney, A. S. Sheoran & S. K. Muthupalani: Characterization and immunogenicity of pyrogenic mitogens SePE-H and SePE-I of Streptococcus equi. Microb Pathog 32, 71-85 (2002)
199. Alouf J. E., H. Knoll & W. Kohler: The family of mitogenic shock-inducing and superantigenic toxins from staphylococci and streptococci. In: Sourcebook of bacterial protein toxins. Eds: Alouf J E, Freer J H, Academic Press, London (1991)
200. Proft T., P. D. Webb, V. Handley & F. J. D.: Two novel superantigens found in both Group A and Group C Streptococcus. Infect Immun 71, 1361-1369 (2003)
201. Timoney J. F., P. J. Timoney & K. L. Strickland: Lysogeny and the immunologically reactive proteins of Streptococcus equi. Vet Rec 115, 148-149 (1984)
202. Collin N. C., N. Chanter & J. A. Mumford: Detection and characterisation of Streptococcus equi and Streptococcus zooepidemicus proteases to identify potential protective immunogens. Presented at the Equine Infectious Diseases VIII: Proceedings of the Eighth International Conference, Dubai, United Arab Emirates, (1998)
203. Sharp M. W., M. J. Prince & J. Gibbens: S. zooepidemicus infection and bovine mastitis. Vet Rec 137, 128 (1995)
204. Anzai T., J. A. Walker, M. B. Blair, T. M. Chambers & J. F. Timoney: Comparison of the phenotypes of Streptococcus zooepidemicus isolated from tonsils of healthy horses and specimens obtained from foals and donkeys with pneumonia. Am J Vet Res 61, 162-166 (2000)
205. Gilmour M. I., P. Park & M. K. Selgrade: Ozone-enhanced pulmonary infection with Streptococcus zooepidemicus in mice. The role of alveolar macrophage function and capsular virulence factors. Am Rev Respir Dis 147, 753-760 (1993)
206. Wibawan I. W., F. H. Pasaribu, I. H. Utama, A. Abdulmawjood & C. Lammler: The role of hyaluronic acid capsular material of Streptococcus equi subsp. zooepidemicus in mediating adherence to HeLa cells and in resisting phagocytosis. Res Vet Sci 67, 131-135 (1999)
207. Walker J. & J. F. Timoney: Molecular basis of variation in protective SzP proteins of Streptococcus zooepidemicus. Am J Vet Res 59, 1129-1133 (1998)
208. Timoney J. F., J. Walker, M. Zhou & J. Ding: Cloning and sequence analysis of a protective M-like protein gene from Streptococcus equi subsp. zooepidemicus. Infect Immun 63, 1440-1445 (1995)
209. Balke E., R. Weiss & A. Seipp: [Hyalurodinase activity of beta-hemolytic streptococci of the Lancefield group C]. Zentralbl Bakteriol Mikrobiol Hyg [A] 259, 194-200 (1985)
210. Romanowska D., Z. Szynkiewicz & J. Rita: Antistreptolysin O titer in horses. Acta Microbiol Pol 35, 91-95 (1986)
211. Simmonds R. S., W. J. Simpson & J. R. Tagg: Cloning and sequence analysis of zoo A, a Streptococcus zooepidemicus gene encoding a bacteriocin-like inhibitory substance having a domain structure similar to that of lysostaphin. Gene 189, 255-261 (1997)
212. Simmonds R. S., L. Pearson, R. C. Kennedy & J. R. Tagg: Mode of action of a lysostaphin-like bacteriolytic agent produced by Streptococcus zooepidemicus 4881. Appl Environ Microbiol 62, 4536-4541 (1996)
213. Beatson S. A., G. L. Sloan & R. S. Simmonds: Zoocin A immunity factor: a femA-like gene found in a group C Streptococcus. FEMS Microbiol Lett 163, 73-77 (1998)
214. Lai A. C., S. Tran & R. S. Simmonds: Functional characterization of domains found within a lytic enzyme produced by Streptococcus equi subsp. zooepidemicus. FEMS Microbiol Lett 215, 133-138 (2002)
215. Mitchell T. J.: Virulence factors and the pathogenesis of disease caused by Streptococcus pneumoniae. Res Microbiol 151, 413-419 (2000)
216. McCullers J. A. & E. I. Tuomanen: Molecular pathogenesis of pneumococcal pneumonia. Front Biosci 6, D877-8889 (2001)
217. Chanter N.: Streptococcus pneumoniae and equine disease. Equine Vet J 26, 5-6 (1994)
218. Burrell M. H., M. E. Mackintosh & C. E. Taylor: Isolation of Streptococcus pneumoniae from the respiratory tract of horses. Equine Vet J 18, 183-186 (1986)
219. Whatmore A. M., S. J. King, N. C. Doherty, D. Sturgeon, N. Chanter & C. G. Dowson: Molecular characterization of equine Isolates of Streptococcus pneumoniae: natural disruption of genes encoding the virulence factors pneumolysin and autolysin. Infect Immun 67, 2776-2782 (1999)
220. Colorni A., A. Diamant, A. Eldar, H. Kvitt & A. Zlotkin: Streptococcus iniae infections in Red Sea cage-cultured and wild fishes. Dis Aquat Org 49, 165-170 (2002)
221. Austin B.: Emerging bacterial fish pathogens. Bull Eur Assoc Fish Pathol 19, 231-234 (1999)
222. Kitao T.: Streptococcal Infections. In: Bacterial diseases of fish. Eds: Inglis V, Roberts R J, Bromage N R, Blackwell, Oxford (1993)
223. Peir G. B. & S. H. Madin: Streptococcus iniae sp. nov., a beta-hemolytic streptococcus isolated from an Amazon freshwater dolphin, Inia geoffrensis. Int J Syst Bacteriol 26, 545-553 (1976)
224. Eldar A., Y. Bejerano & H. Bercovier: Streptococcus shiloi and Streptococcus difficile: two new Streptococcal species causing a meningoencephalitis in fish. Curr Microbiol 28, 139-143 (1994)
225. Weinstein M. R., M. Litt, D. A. Kertesz, P. Wyper, D. Rose, M. Coulter, A. McGeer, R. Facklam, C. Ostach, B. M. Willey, A. Borczyk & D. E. Low: Invasive infections due to a fish pathogen, Streptococcus iniae. N Engl J Med 337, 589-594 (1997)
226. Shoemaker C. A., P. H. Klesius & J. J. Evans: Prevalence of Streptococcus iniae in tilapia, hybrid striped bass, and channel catfish on commercial fish farms in the United States. Am J Vet Res 62, 174-177 (2001)
227. Peir G. B. & S. H. Madin: Isolation and characterization of a second isolate of Streptococcus iniae. Int J Syst Bacteriol 28, 311-314 (1978)
228. Bromage E. S., A. Thomas & L. Owens: Streptococcus iniae, a bacterial infection in barramundi Lates calcarifer. Dis Aquat Organ 36, 177-181 (1999)
229. Eldar A. & C. Ghittino: Lactococcus garvieae and Streptococcus iniae infections in rainbow trout Oncorhynchus mykiss: similar, but different diseases. Dis Aquat Org 36, 227-231 (1999)
230. Neely M. N., J. D. Pfeifer & M. Caparon: Streptococcus-zebrafish model of bacterial pathogenesis. Infect Immun 70, 3904-3914 (2002)
231. Fuller J. D., D. J. Bast, V. Nizet, D. E. Low & J. C. S. de Azavedo: Streptococcus iniae Virulence Is Associated with a Distinct Genetic Profile. Infect Immun 69, 1994-2000 (2001)
232. Fuller J. D., A. C. Camus, C. L. Duncan, V. Nizet, D. J. Bast, R. L. Thune, D. E. Low & J. C. De Azavedo: Identification of a streptolysin S-associated gene cluster and its role in the pathogenesis of Streptococcus iniae disease. Infect Immun 70, 5730-5739 (2002)
233. Zlotkin A., S. Chilmonczyk, M. Eyngor, A. Hurvitz, C. Ghittino & A. Eldar: Trojan horse effect: phagocyte-mediated Streptococcus iniae infection of fish. Infect Immun 71, 2318-2325 (2003)
234. Barnes A. C., F. M. Young, M. T. Horne & A. E. Ellis: Streptococcus iniae: serological differences, presence of capsule and resistance to immune serum killing. Dis Aquat Org 53, 241-247 (2003)
235. Bachrach G., A. Zlotkin, A. Hurvitz, D. L. Evans & A. Eldar: Recovery of Streptococcus iniae from diseased fish previuosly vaccinated with a Streptococcus vaccine. Appl Environ Microbiol 67, 3756-3758 (2001)
236. Lukomski S., J. Burns, E. H., P. R. Wyde, A. Podbielski, J. Rurangirwa, D. K. Moore-Poveda & J. M. Musser: Genetic inactivation of an extracellular cysteine protease (SpeB) expressed by Streptococcus pyogenes decreases resistance to phagocytosis and dissemination to organs. Infect Immun 66, 771-776 (1998)
237. Taylor S. L., L. Jaso-Friedmann, A. B. Allison, A. Eldar & D. L. Evans: Streptococcus iniae inhibition of apoptosis of nonspecific cytotoxic cells: a mechanism of activation of innate immunity in teleosts. Dis Aquat Org 46, 15-21 (2001)
238. Evans D. L., S. L. Taylor, J. H. Leary III, G. R. Bishop, A. Eldar & L. Jaso-Friedmann: In vivo activation of tilapia nonspecific cytotoxic cells by Streptococcus iniae and amplification with apoptosis regulatory factor(s). Fish Shellfish Immunol 10, 419-434 (2000)
239. Devriese L. A., J. Hommez, R. Kilpper-Bälz & K. H. Schleifer: Streptococcus canis sp. nov.: a species of group G streptococci from animals. Int J Syst Bacteriol 36, 422-425 (1986)
240. Takeda N., K. Kikuchi, R. Asano, T. Harada, K. Totsuka, T. Sumiyoshi, T. Uchiyama & S. Hosoda: Recurrent septicemia caused by Streptococcus canis after a dog bite. Scand J Infect Dis 33, 927-928 (2001)
241. Whatmore A. M., K. H. Engler, G. Gudmundsdottir & A. Efstratiou: Identification of isolates of Streptococcus canis infecting humans. J Clin Microbiol 39, 4196-4199 (2001)
242. Bert F. & N. Lambert-Zechovsky: Septicemia caused by Streptococcus canis in a human. J Clin Microbiol 35, 777-779 (1997)
243. DeWinter L. M., D. E. Low & J. F. Prescott: Virulence of Streptococcus canis from canine streptococcal toxic shock syndrome and necrotising fasciitis. Vet Microbiol 70, 95-110 (1999)
244. Miller C. W., J. F. Prescot, K. A. Mathews, S. D. Betschel, J. A. Yager, V. Guru, L. DeWinter & D. E. Low: Streptococcal toxic shock syndrome in dogs. J Am Vet Med Assoc 209, 1421-1426 (1996)
245. Cleary P. P., J. Peterson, C. Chen & C. Nelson: Virulent human strains of group G streptococci express a C5a peptidase enzyme similar to that produced by group A streptococci. Infect Immun 59, 2305-2310 (1991)
246. Yutsudo T., K. Okumura, M. Iwasaki, A. Hara, S. Kamitani, W. Minamide, H. Igarashi & Y. Hinuma: The gene encoding a new mitogenic factor in a Streptococcus pyogenes strain is distributed only in group A streptococci. Infect Immun 62, 4000-4004 (1994)
247. Simpson W. J., J. C. Robbins & P. P. Cleary: Evidence for group A-related M protein genes in human but not animal-associated group G streptococcal pathogens. Microb Pathog 3, 339-350 (1987)
248. Schnitzler N., A. Podbielski, G. Baumgarten, M. Mignon & A. Kaufhold: M or M-like protein gene polymorphisms in human group G streptococci. J Clin Microbiol 33, 356-363 (1995)
249. Fischetti V. A.: Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev 2, 285-314 (1989)
250. Ullberg M., I. Karlsson, B. Wiman & G. Kronvall: Two types of receptors for human plasminogen on group G streptococci. APMIS 100, 21-28 (1992)
251. Lammler C., C. Frede, K. Gurturk, A. Hildebrand & H. Blobel: Binding activity of Streptococcus canis for albumin and other plasma proteins. J Gen Microbiol 134(Pt 8), 2317-2323 (1988)
252. DeWinter L. M. & J. F. Prescott: Relatedness of Streptococcus canis from canine Streptococcal toxic shock syndrome and necrotizing fasciitis. Can J Vet Res 63, 90-95 (1999)
253. Soedarmanto I. & C. Lammler: Comparative studies on streptococci of serological group G isolated from various origins. Zentralbl Veterinarmed [B] 43, 513-523 (1996)
254. Clark R. B., J. F. Berrafati, J. M. Janda & E. J. Bottone: Biotyping and exoenzyme profiling as an aid in the differentiation of human from bovine group G streptococci. J Clin Microbiol 20, 706-710 (1984)
255. Tapsall J. W. & E. A. Phillips: Streptococcus pyogenes streptolysin O as a cause of false-positive CAMP reactions. J Clin Microbiol 19, 534-537 (1984)
256. Gurturk K. & C. Lammler: Purification and partial characterization of a cohaemolysin (CAMP-factor) produced by Streptococcus canis. FEMS Microbiol Immunol 2, 97-102 (1990)
257. Hardie J. M.: Other streptococci. In: Bergey's manual of systematic bacteriology. Eds: Sneath P H A, Mair N S, Sharpe M E, Holt J G, Williams & Wilkins, Baltimore (1986)
258. Farrow J. A. E., J. Kruze, B. A. Phillips, A. J. Bramley & M. D. Collins: Taxonomic studies on Streptococcus bovis and Streptococcus equinus: description of Streptococcus alactolyticus sp. nov. and Streptococcus saccharolyticus sp. nov. Syst Appl Microbiol 5, 467-482 (1984)
259. Brooker J. D., L. A. O'Donovan, I. Skene, K. Clarke, L. Blackall & P. Muslera: Streptococcus caprinus sp. nov., a tannin-resistant ruminai bacterium from feral goats. Lett Appl Microbiol 18, 313-318 (1994)
260. Osawa R., T. Fujisawa & L. I. Sly: Streptococcus gallolyticus sp. nov.; gallate degrading organisms formerly assigned to Streptococcus bovis. Syst Appl Microbiol 18, 74-78 (1995)
261. Sly L. I., M. M. Cahill, R. Osawa & T. Fujisawa: The tannin-degrading species Streptococcus gallolyticus and Streptococcus caprinus are subjective synonyms. Int J Syst Bacteriol 47, 893-894 (1997)
262. Devriese L. A., P. Vandamme, B. Pot, M. Vanrobaeys, K. Kersters & F. Haesebrouck: Differentiation between Streptococcus gallolyticus Strains of Human Clinical and Veterinary Origins and Streptococcus bovis Strains from the Intestinal Tracts of Ruminants. J Clin Microbiol 36, 3520-3523 (1998)
263. Stewart C. S., H. J. Flint & M. P. Bryant: The rumen bacteria. In: The rumen microbial ecosystem. Eds: Hobson P N, Stewart C S, Blackie Academic and Professional, London (1997)
264. Nelms L. F., D. A. Odelson, T. R. Whitehead & R. B. Hespell: Differentiation of ruminai and human Streptococcus bovis strains by DNA homology and 16S rRNA probes. Curr Microbiol 31, 294-300 (1995)
265. De Herdt P., F. Haesebrouck, R. Ducatelle, B. De Groote & L. A. Devriese: Streptococcus bovis infections in pigeons: virulence of different serotypes. Vet Microbiol 41, 321-332 (1994)
266. Vanrobaeys M., P. De Herdt, F. Haesebrouck, R. Ducatelle & L. A. Devriese: Secreted antigens as virulence associated markers in Streptococcus bovis strains from pigeons. Vet Microbiol 53, 339-348 (1996)
267. Vanrobaeys M., P. De Herdt, R. Ducatelle, W. Creten & F. Haesebrouck: Extracellular proteins and virulence of Streptococcus bovis isolates from pigeons. Vet Microbiol 59, 59-66 (1997)
268. Vanrobaeys M., F. Haesebrouck, R. Ducatelle & P. De Herdt: Identification of virulence associated markers in the cell wall of pigeon Streptococcus gallolyticus strains. Vet Microbiol 73, 319-325 (2000)
269. Vanrobaeys M., P. De Herdt, G. Charlier, R. Ducatelle & F. Haesebrouck: Ultrastructure of surface components of Streptococcus gallolyticus (S. bovis) strains of differing virulence isolated from pigeons. Microbiology 145(Pt 2), 335-342 (1999)
270. Whitford M. F., M. A. McPherson, R. J. Forster & R. M. Teather: Identification of bacteriocin-like inhibitors from rumen Streptococcus spp. and isolation and characterization of Bovicin 255. Appl Environ Microbiol 67, 569-574 (2001)